Background: There is good agreement that Theory of Mind (ToM) and executive function are impaired to some degree in many patients with schizophrenia. However, few studies have set out to investigate as a primary aim the relationship between these 2 cognitive domains in the disorder. Methods: A systematic review was carried out to identify all published studies in which tests of ToM and executive function were administered to individuals with schizophrenia, and in which the relation between scores was reported. Results: The review revealed 17 relevant studies, of which 8 reported the relation between ToM and executive function using multivariate statistics. These all concurred in showing that ToM ability continued to predict an individual having schizophrenia (rather than being a control participant) once executive function was controlled for. Conclusions: There is very good agreement that ToM and executive function impairments in schizophrenia are independent of one another. Implications are discussed for the putative brain systems involved in the disorder and for its cognitive rehabilitation.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.